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Abstract
Alternative splicing contributes to diversiﬁcation of gene function, yet consequences of splicing on functions of
speciﬁc gene products is poorly understood. The major transcription factor TCF7L2 undergoes alternative splicing but
the biological signiﬁcance of TCF7L2 isoforms has remained largely to be elucidated. Here, we ﬁnd that the TCF7L2 Eisoforms maintain, whereas the M and S isoforms disrupt morphogenesis of 3D-epithelial cell-derived organoids via
regulation of epithelial-mesenchymal transition (EMT). Remarkably, TCF7L2E2 antagonizes, whereas TCF7L2M2/S2
promotes EMT-like effects in epithelial cells induced by transforming growth factor beta (TGFβ) signaling. In addition,
we ﬁnd TGFβ signaling reduces the proportion of TCF7L2E to TCF7L2M/S protein in cells undergoing EMT. We also
ﬁnd that TCF7L2 operates via TGFβ-Smad3 signaling to regulate EMT. Collectively, our ﬁndings unveil novel isoformspeciﬁc functions for the major transcription factor TCF7L2 and provide novel links between TCF7L2 and TGFβ
signaling in the control of EMT-like responses and epithelial tissue morphogenesis.

Introduction
Protein-encoding genes are limited in number to
account for the biological complexity of living organisms1.
Post-transcriptional mechanisms, including alterative
splicing of multi-exonic genes, can lead to increase in the
repertoire of cellular proteins, and may contribute to
biological diversity. Characterizing the functional implications of distinct splice isoforms of a gene should add
insight into the role of alternative splicing in biological
versatility. Elucidating the functional signiﬁcance of different isoforms may also help ascertain how perturbation
of expression of mRNA and protein isoforms contributes
to disease.
Transcription Factor-7 Like-2 (TCF7L2) is a member of
T-cell factors (TCF) family of high mobility group (HMG)
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box-containing transcription factor2,3. TCF7L2 acts in
Wnt-β-catenin-signaling-dependent and independent
manner to regulate transcription and biological responses
including cell proliferation and fate determination4–9.
TCF7L2 is encoded by the TCF7L2 gene, with the open
reading frame comprising 17 exons3. Alternative splicing
of exons 4, 13, 14, 15, or 16 in the TCF7L2 pre-mRNA can
generate several TCF7L2 mRNA isoforms. In particular,
alternative splicing of exons 13–16 generates one of three
predominate sets of TCF7L2 isoforms termed extended
(E), medium (M), and short (S)3,6,10–12. A cysteine-clamp
(C-clamp) domain and C-terminal binding protein (CtBP)
binding motifs are present C-terminally in the E isoforms,
which are absent in the M isoforms, and only a partial Cclamp domain is present in the S isoforms3,11. Each the E,
M, and S isoforms may also retain or lack certain amino
acids, including by splicing in or out of exon 4, thus
leading to further complexity3,13. The E, M, and S TCF7L2
protein isoforms share exon 1-encoded N-terminal
β-catenin binding domain, which is critical for control of
the Wnt pathway3,14. These TCF7L2 isoforms also share
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an HMG-box domain and a nuclear localization sequence
(NLS) motif, encoded by exons 10–12, which contribute
to their ability to control gene expression3.
Despite a great deal of interest3,10,11,15, the functional
signiﬁcance of TCF7L2 isoforms remains poorly elucidated. TCF7L2 is expressed in epithelial tissues including
the mammary glands, skin, and gastrointestinal tract, and
may contribute to the maintenance and differentiation of
epithelial cells15–19. However, TCF7L2 isoform-dependent
roles in epithelial cell and tissue maintenance remain to be
identiﬁed, and are, thus, the focus of this study.
The ability of epithelial cells to transdifferentiate into a
mesenchymal phenotype via the epithelial-mesenchymal
transition (EMT), is fundamental to the developing
organism, and contributes to postnatal mammary gland
development and wound healing20,21. Epithelial cells
undergoing EMT lose their apical–basal polarity and
epithelial phenotype and gain ﬁbroblastic-like features,
which occur in part due to loss or mislocalization of
cell–cell junctional epithelial markers including Ecadherin22,23. EMT also leads to increased cell migration
and invasion24. EMT can be reinitiated in pathological
conditions including ﬁbrosis and cancer, where it may
contribute to invasiveness and metastatic behavior of
tumor cells25. The importance of EMT in normal and
disease conditions has raised much interest in the
underpinning and regulation of EMT. The mechanisms
that regulate EMT remain to be fully investigated.
This study reveals novel isoform-speciﬁc functions for
TCF7L2 in EMT and organoid morphogenesis regulation.
Using three-dimensional epithelial cell-derived organoid
models, gain and loss of function studies reveal that
whereas E-isoforms suppress, the M or S isoforms promote EMT. We also ﬁnd that the β-catenin domain within
TCF7L2 is not required for the antagonistic functions of
the TCF7L2 isoforms, suggesting that Wnt-β-catenin
signaling may not regulate TCF7L2 role in EMT.
Importantly, we ﬁnd that the secreted factor transforming
growth factor beta (TGFβ), a potent inducer of EMT,
reduces the protein abundance of TCF7L2 isoforms protein ratio of E to S/ M in order to promote EMT in
epithelial cells-derived organoids. Collectively, our study
points to an isoform-speciﬁc functions for TCF7L2
mediated by TGFβ signaling in regulating EMT-like
effects in epithelial cell-derived organoids.

Results
Expression of TCF7L2 isoforms in mammary epithelial cells

Exons 13–16 within TCF7L2 pre-mRNA can be alternatively spliced giving rise to several iterations of Cterminal variant E, M, and S isoforms (Fig. S1A). Exon 4
inclusion or exclusion contributes to additional variations
in these TCF7L2 isoforms. A key question that has
remained to be investigated is the functional signiﬁcance
Ofﬁcial journal of the Cell Death Differentiation Association
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of the TCF7L2 E, M, and S isoforms. We sought to
determine TCF7L2 role in EMT, which is fundamental for
shaping the developing organism and contributes to
homeostasis and diseases. We employed the mouse
mammary epithelial NMuMG cells, a widely used cellular
model to study EMT including in the context of threedimensional (3D) culture system26–29. First, we characterized TCF7L2 isoforms proﬁle in lysates of subconﬂuent NMuMG cell monolayers. Immunoblotting
analyses revealed anti-TCF7L2-immunoreactive-protein
species at 75 and 60 kD, potentially corresponding to the
E and S/M isoforms, respectively, with the ﬁrst showing a
higher abundance than the latter (Fig. S1A and S1B). RTPCR analyses indicated that the C-variant E2, E3, E4, M1,
M2, and S2 isoforms of TCF7L2, with or without exon 4,
may be expressed in NMuMG cells (Fig. S1E and S1F).
TCF7L2 regulates EMT-like responses in organoids in an
isoform-speciﬁc manner

That the E, S, and M TCF7L2 isoforms are expressed in
the mammary epithelial cells raised the key question of
their functional signiﬁcance in these cells. We, ﬁrst, subcloned and sequence-veriﬁed TCF7L2 E2, E3, E4, M1, M2,
and S2 cDNA into an expression plasmid (M&M, and Fig.
S1C–S1F). We, then, used a 3D-culture model, employing
Matrigel as a source of extracellular matrix (ECM), to
determine the role of TCF7L2 isoforms in EMT-like
responses27,29. 3D culturing of cells supports the organization of proliferating epithelial cells into multicellular
structures characterized by hollow spherical or acinar
morphology with apical/basal polarity, akin to glandular
epithelial tissues in vivo, and that are also termed ‘acini’ or
‘organoids’26,27,30. EMT induction by the secreted protein
TGFβ, a potent inducer of EMT in development and
disease including cancer21,23,25, can lead to many cellular
changes including cell–cell and cell–matrix detachments,
apical–basal polarity loss, and invasion, manifesting as
hollow-lumen ﬁlling and deformation, including invasiveness and budding, of the organoids. The epithelial
marker and adherens junctional protein E-cadherin contributes to epithelial tissue polarity and morphology20.
Loss and/or mislocalization of E-cadherin is considered a
key hallmark of EMT (Fig. 1d)31.
We found that expression of TCF7L2E2 isoform, with
or without exon 4, suppressed TGFβ-induced ﬁlling and
deformation of 3D-NMuMG cell-derived acini (Figs.
1a–c and S2A). In addition, immunocytochemical analysis showed that overexpression of the TCF7L2E2 isoform blocked TGFβ-induced reduction in the protein
abundance and/or mislocalization of E-cadherin in
NMuMG cell-derived acini (Fig. 1d). Together, these
data suggested that TCF7L2E2 may negatively regulate
the induction of EMT-like effects in epithelial cellderived organoids. These data also suggested that
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Fig. 1 (See legend on next page.)

overall, exon 4-encoding region may not affect Eisoforms suppression of EMT.
Next, we compared the effect of expression of TCF7L2
E3, E4, M1, M2, or S2 to that of the E2 isoform on acinar
morphology in the absence or presence of TGFβ. We found,
similar to TCF7L2E2, overexpressed E3 and E4 isoforms
suppressed TGFβ-induced EMT (Figs. 1e–g and S2B). In
contrast, overexpressed TCF7L2 M1, M2, and S2 led to
ﬁlling and deformation (Figs. 1e–g and S2B), and reduced
Ofﬁcial journal of the Cell Death Differentiation Association

protein level and mislocalization of E-cadherin (Fig. 1h), in
the NMuMG cell-derived organoids, even in the absence of
TGFβ, suggesting that these isoforms might promote EMTlike effects. Our data, also, suggested that the EMT-like
effects induced by the TCF7L2 M2 and S2 isoforms may
not be affected by exon 4-coding peptide (Figs. 1i–l and
S2C). Collectively, these data suggest that C-terminal
TCF7L2 E variants may suppress, while the M and S variants may induce EMT-like effects in epithelial cells.
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(see ﬁgure on previous page)
Fig. 1 TCF7L2 isoforms differentially regulate the morphogenesis of three-dimensional mammary epithelial cell-derived organoids.
a–d TCF7L2E2 expression suppresses TGFβ-induced EMT of 3D-NMuMG cell-derived organoids. a Lysates of NMuMG cells transfected with the vector
control or a plasmid-containing cDNA encoding MYC-tagged TCF7L2E2 protein with (E2-e4) or without (E2) exon 4-encoded amino acids, were
subjected to immunoblotting with MYC or actin antibody, with the latter used as loading control. b Representative DIC images of 8-day-old
untreated or TGFβ-stimulated NMuMG cells transfected as described in 1 A. Green and red arrowheads indicate hollow center and ﬁlled/deformed
acini, respectively. Scale bar indicates 50 μm. c Bar graph of average percent (±SEM) of hollow acinar of untreated or TGFβ-stimulated 8-day old 3Dorganoids derived from NMuMG cells transfected as in 1 A from three biological replicates of the experiment, including the one shown in 1B (ANOVA:
***P ≤ 0.001). Expression of TCF7L2E2, with or without exon 4, suppressed the ability of TGFβ to promote acini ﬁlling of epithelial cell-derived
organoids. d Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody-red) and nuclear- (Hoechst 33258, blue) stained
formalin-ﬁxed untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from mammary epithelial cells transfected and subjected to threedimensional culture as described in 1a–c. Scale bar indicates 50 μm. TCF7L2E2 expression suppressed TGFβ‘s ability to decrease the protein
abundance and/or mislocalization of E-cadherin, considered as key hallmarks of TGFβ-induced EMT. e–h E vs M/S TCF7L2 isoform expression has
opposing effects on EMT induction of NMuMG cell-derived organoids. e Lysates of NMuMG cells transfected with vector control or plasmidcontaining cDNA encoding MYC-tagged E2, E3, E4, S2, M1, or M2 TCF7L2 isoform, were subjected to MYC or actin immunoblotting, with the latter as
a loading control. f Representative DIC images of untreated or TGFβ-stimulated 8-day old 3D-organoids derived from NMuMG cells transfected as
described in 1E. Green and red arrowheads indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. g Bar graph of
average percent (±SEM) of hollow acinar of untreated or TGFβ-stimulated 8-day old 3D-organoids derived from NMuMG cells transfected as in 1E
from three biological replicates of the experiment, including the one shown in 1 F (ANOVA: ***P ≤ 0.001). Like E2, E3, or E4 expression suppressed
TGFβ-induced acini ﬁlling, whereas S2, M1, or M2 expression promoted acini ﬁlling even in the absence of exogenous TGFβ. h Representative
ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear- (Hoechst 33258, blue) stained formalin-ﬁxed untreated or
TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected and subjected to three-dimensional culture as described in 1e and
f. Scale bar indicates 50 μm. Similar to E2, E3, and E4 expression suppressed TGFβ-mediated loss and mislocalization of E-cadherin. M1, M2, or S2
expression induced loss and mislocalization of E-cadherin even in absence of exogenous TGFβ. i–l Expression of TCF7L2M or TCF7L2S isoforms, with
or without exon 4, regulates EMT. i Lysates of NMuMG cells transfected with vector control, or plasmid-containing cDNA encoding MYC-tagged E2,
M2, or S2 TCF7L2 isoforms with exon 4-encoded amino acids (E2-e4, M2-e4, and S2-e4) were subjected to MYC or actin immunoblotting, with the
latter as a loading control. Asterix (*) indicates a non-speciﬁc immunoreactive band. j Representative DIC images of untreated or TGFβ-stimulated 8day-old 3D-organoids derived from NMuMG cells transfected as in 1I. Green and red arrowheads indicate hollow center and ﬁlled/deformed acini,
respectively. Scale bar indicates 50 μm. k Bar graph of average percent (±SEM) of hollow acinar untreated or TGFβ-stimulated 8-day old 3D-organoids
derived from NMuMG cells transfected as described in 1I from three biological replicates of the experiment, including the one shown in 1 J (ANOVA:
***P ≤ 0.001). l Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear- (Hoechst 33258, blue) stained
formalin-ﬁxed untreated or TGFβ-treated 8-day old 3D-organoids derived from NMuMG cells transfected and subjected to three-dimensional culture
as described in 1i–k. Scale bar indicates 50 μm. E2 and M2/S2, with or without exon 4, prevent and promote, respectively, alterations in E-cadherin
abundance/localization.

TCF7L2 C-variant isoforms may regulate EMT
independently of Wnt-β-catenin signaling

TCF7L2 contributes to the canonical Wnt-β-cateninsignaling pathway and responses, raising the question
whether Wnt signaling inﬂuences the isoform-speciﬁc
effects of TCF7L2 in EMT. TCF7L2 associates via its
β-catenin binding domain with the transcriptional regulator β-catenin to regulate Wnt-dependent gene
expression and responses3,32. We, thus, determined the
effect of deletion of the β-catenin binding domain on the
ability of TCF7L2 isoforms to regulate EMT in NMuMG
cell-derived acini. Deletion of the β-catenin domain did
not affect the ability of the TCF7L2E2 isoform to inhibit
TGFβ-induced EMT in 3D-epithelial cell-derived acini
(Figs. 2a–d and S3A). We, also, found the β-catenin
binding domain deletion did not seem to alter S2 or M2
TCF7L2 isoform promotion of EMT-like responses
(Figs. 2a–d and S3A). Thus, these data suggest that the
canonical Wnt-β-catenin signaling may not be essential
for TCF7L2 isoform-speciﬁc functions in EMT-like
effects. On the other hand, we found blocking endogenous TGFβ signaling in the NMuMG cell-derived
Ofﬁcial journal of the Cell Death Differentiation Association

organoids suppressed the ability of the M and S isoforms
to promote ﬁlling and morphological deformation, and
loss or mislocalization of E-cadherin in these acini (Figs.
2e–h and S3B and data not shown). Together, these data
suggest that the opposing effects on EMT of overexpressed C-terminal isoform variants of TCF7L2 in
3D-epithelial cell-derived organoids may not require
β-catenin-mediated signaling.
Endogenous TCF7L2 acts in an isoform-speciﬁc manner to
regulate acini morphology

We next used RNA interference (RNAi) to characterize
the role of endogenous TCF7L2 in EMT-like effects in
epithelial cell-derived acini. We generated two short
hairpin RNA (shRNA)-expressing constructs RNA1i and
RNA2i that target two distinct constitutive regions of
TCF7L2 mRNA (Table 2 and Fig. S1A), to knockdown all
TCF7L2 isoforms including E, M, and S isoforms in
NMuMG cells (Fig. 3a, b). Knockdown of TCF7L2 promoted EMT-like behavior in the NMuMG cell-derived
acini even in the absence of TGFβ as compared to the
vector control-transfected cells (Figs. 3c–e and S4A). The
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Fig. 2 (See legend on next page.)

TCF7L2 knockdown-induced EMT-like responses were
reversed by suppression of endogenous TGFβ signaling.
Importantly, expression of RNAi-resistant protein
TCF7L2E2-1ir or TCF7L2E2-2ir reversed EMT induction
by the respective TCF7L2 shRNA, excluding the possibility that the RNAi-induced EMT phenotype was due to off
target effects (Figs. 3f–i and S4B). On the other hand,
expression of the corresponding TCF7L2M2-1ir or
TCF7LS2-1ir rescue proteins did not reverse the EMT
responses induced by TCF7L2 shRNA1 (Fig. S4C–S4G).
Ofﬁcial journal of the Cell Death Differentiation Association

Altogether, these data are consistent with the idea that at
endogenous levels, TCF7L2E isoforms suppress EMT.
We next generated the RNAi plasmids RNA-M2i and
RNA-S2i encoding TCF7L2 shRNA-M2i and shRNA-S2i
to selectively knockdown the TCF7L2 M2 and S2 isoforms,
respectively (Table 2, Figs 4a, e, S1A). Remarkably,
TCF7L2M2 knockdown suppressed acini TGFβ-induced
ﬁlling and deformation, and E-cadherin loss or mislocalization (Figs. 4b–d and S5A). Similarly, TCF7L2S2
knockdown reversed TGFβ-induced EMT-like effects (Figs.
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(see ﬁgure on previous page)
Fig. 2 TCF7L2 isoforms may act in a β-catenin-independent manner to regulate TGFβ-induced EMT in 3D-mammary epithelial cell-derived
organoids. a–d Deletion of β-catenin binding domain does not impact the ability of expressed TCF7L2 isoforms to regulate EMT. a Lysates of
NMuMG cells transfected with vector control or a plasmid-containing cDNA encoding MYC-tagged full length or a β-catenin binding domain
deletion mutant (ΔN) version of TCF7L2 E2, M2, or S2 were subjected to MYC and actin immunoblotting, with the latter as a loading control.
b Representative DIC images of untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected as described in 2a.
Green and red arrowheads indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. c Bar graph of average percent
(±SEM) of hollow acinar untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected as in 2a from three biological
replicates of the experiment, including the one shown in 2b (ANOVA: ***P ≤ 0.001). d Representative ﬂuorescence microscopy scans of E-cadherin- (Ecadherin antibody, red) and nuclear- (Hoechst 33258, blue) stained formalin-ﬁxed untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from
NMuMG cells transfected and subjected to three-dimensional culture as described in 2A-2C. Scale bar indicates 50 μm. e–h S2 expression promotes
EMT in a TGFβ signaling-dependent manner. e Lysates of NMuMG cells transfected with vector control or a plasmid-containing cDNA encoding MYC/
TCF7L2S2 were subjected to MYC and actin immunoblotting, with the latter as a loading control. f Representative DIC images of 8-day-old 3Dorganoids derived from NMuMG cells transfected as described in 2e. The organoid cultures were incubated with the TGFβ signaling inhibitor
SB431542 (+KI), a small molecule inhibitor of the ser/thr kinase activity of the TGFβ type I receptor, or with the vehicle (−KI). Green and red
arrowheads indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. g Bar graph of average percent (±SEM) of
hollow acinar vehicle-treated (−KI) or TGFβ signaling inhibitor-treated (+KI) 8-day-old 3D-organoids derived from mammary epithelial cells
transfected as described in 2e from three biological replicates of the experiment, including the one shown in 2f (ANOVA: ***P ≤ 0.001, ns not
signiﬁcant). Inhibition of basal TGFβ signaling reversed the ability of TCF7L2S2 isoform to promote acini ﬁlling. h Representative ﬂuorescence
microscopy scans of E-cadherin (E-cadherin antibody, red) and nuclear (Hoechst 33258, blue) stained formalin-ﬁxed 8-day old 3D-organoids derived
from NMuMG cells transfected and treated as described in 2e–g. Scale bar indicates 50 μm. Inhibition of basal TGFβ signaling reversed the ability of
TCF7L2S2 isoform to promote loss and mislocalization of E-cadherin.

4f–h, and S5B). Further, expression of RNAi-resistant
protein TCF7L2M2-M2ir and TCF7L2S2-S2ir reversed
EMT suppression by shRNA-M2i and shRNA-S2i,
respectively, suggesting that endogenous TCF7L2 M and S
isoforms promote TGFβ-induced EMT in NMuMG cellderived organoids (Figs. 4b–d, f–h and S5A, S5B). Taken
together, our data demonstrate that endogenous TCF7L2
regulates EMT-like effects in an isoform-speciﬁc manner.
Whereas TCF7L2M/S isoforms promote, TCF7L2E isoforms suppress EMT-like effects in epithelial cells.
TGFβ regulates TCF7L2 abundance in epithelial cells
undergoing EMT

The identiﬁcation of a novel isoform-speciﬁc function
of TCF7L2 in EMT led us next to the fundamental
question of how TCF7L2 might be regulated in EMT. We
ﬁrst determined if EMT affects the abundance and subcellular localization of TCF7L2 in epithelial cells. Immunocytochemistry analyses revealed that TCF7L2 is
predominately nuclear in NMuMG epithelial cells
(Fig. 5a). Remarkably, the protein abundance of TCF7L2
was reduced by ~75% in cells undergoing TGFβ-induced
EMT (Fig. 5a). qRT-PCR analyses revealed that the
abundance of TCF7L2 mRNA was reduced by close to
80% in cells undergoing EMT (Figs. 5b and S6A, S6B).
Interestingly, TGFβ signaling activation decreased the
protein abundance of TCF7L2 E isoforms to a greater
extent than that of the S/M isoforms in cells leading to a
decrease in the protein proportion of TCF7L2 E isoforms
to that of the S/M isoforms (Fig. 5c, d). In other experiments, we found that the TCF7L2 E isoforms are also
expressed at a higher relative abundance compared to the
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S/M isoforms in the NMuMG cell-derived organoids (Fig.
5e, f). Importantly, increased TGFβ signaling (Fig. 5e,
second and third panels, respectively), reduced the protein
abundance of the TCF7L2 isoforms with an overall E to
M/S isoform reduction in protein ratio in the NMuMGderived organoids (Fig. 5e, f). We, also, found that TGFβ
signaling increased the protein abundance of the EMTinducing transcription factor Smad interacting protein
(SIP1), or Zeb2, while decreasing the SIP1-repressed target E-cadherin suggesting TGFβ-induced EMT-like
effects in these organoids (Fig. S6C). In studies investigating the E-S/M functional interplay, we found expression of the TCF7L2E2 suppressed TCF7L2S2 promotion
of EMT (Figs. 5g–i and S6D, S6E). Reciprocal coimmunoprecipitations (Co-IP) revealed that E2 and S2 interact
and support the idea that these isoforms may form hetero- and homo-oligomers (Fig. 5j–m). Altogether, these
data suggest that TGFβ signaling reduces the relative
protein abundance of E isoforms as compared to that of
the M/S isoforms of TCF7L2, which may lead to increase
in M/S isoform-containing TCF7L2 protein complexes,
which may facilitate EMT-like responses.
We next asked if TCF7L2 might be regulated by TGFβ
signaling in other epithelial cells besides NMuMG cells.
Keratinocytes represent a specialized skin epithelial
tissue-derived cell type. The human epidermal HaCaT
keratinocytes is a widely used cellular model in studies of
TGFβ-signaling and responses including EMT33–35. In
our analyses, TGFβ promoted a cuboidal to elongated
phenotype change in monolayer cultures of HaCaT cells
(Fig. 6a). RT-PCR and immunoblotting analyses demonstrated that the TCF7L2 E and S/M isoforms are
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Fig. 3 (See legend on next page.)
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(see ﬁgure on previous page)
Fig. 3 Endogenous TCF7L2 acts in an isoform-dependent manner to regulate mammary epithelial-acini morphology. a Lysates of NMuMG
cells transfected with an RNAi vector control (−) or an RNAi plasmid encoding shRNA1 (TCF7L2-1i) or shRNA2 (TCF7L2-2i) targeting two distinct
regions of TCF7L2 mRNA (Table 2), were subjected to TCF7L2 or actin immunoblotting, the latter as a loading control. b Bar graph depicts average of
actin-normalized protein abundance of 75 kDa (E isoforms) and 60 kDa (M and S isoforms) (±SEM) of TCF7L2-immunoreactive protein species in lysates
of NMuMG cells transfected as in 3a, and expressed relative to the RNAi vector control from four biological replicates of the experiment, including the
one shown in 3a (ANOVA: ***P ≤ 0.001). shRNA1 and shRNA2 reduced the protein abundance of endogenous TCF7L2. c Representative DIC images of
8-day-old untreated, KI-treated, or TGFβ-treated 3D-organoids derived from NMuMG cells transfected and analyzed as described in 3a and b. Green
and red arrowheads indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. d Bar graph of average percent (±SEM) of
hollow acinar untreated, KI, or TGFβ-incubated 8-day-old 3D-organoids derived from NMuMG cells transfected as described in 3a from three biological
replicates of the experiment, including the one shown in 3c (ANOVA: ***P ≤ 0.001). TCF7L2-1i and 2i promoted acini ﬁlling even in the absence of
TGFβ, and which was reversed by TGFβ signaling inhibition (KI). e Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody,
red) and nuclear- (Hoechst 33258, blue) stained formalin-ﬁxed 8-day-old untreated, KI or TGFβ-treated 3D-organoids derived from NMuMG cells
transfected and subjected to three-dimensional culture as described in 3a–d. Scale bar indicates 50 μm. TCF7L2-1i and 2i promoted loss and
mislocalization of E-cadherin even in the absence of TGFβ, which were reversed by TGFβ signaling inhibition (KI). f Lysates of NMuMG cells transfected
with RNAi vector control (−), or one expressing TCF7L2-1i or 2i, together with a control expression vector, or a plasmid-containing cDNA encoding
hemagglutinin (HA)-tagged TCF7L2E2 version that is sensitive to both TCF7L2-1i and −2i (+), only to TCF7L2-2i (1ir), or only TCF7L2-1i (2ir) were
subjected to HA and actin immunoblotting, with the latter as a loading control. g Representative DIC images of 8-day-old untreated or
TGFβ-stimulated 3D-organoids derived from NMuMG cells transfected as described in 3f. Green and red arrowheads indicate hollow center and ﬁlled/
disrupted acini, respectively. Scale bar indicates 50 μm. h Bar graph of average percent (±SEM) of hollow acinar untreated or TGFβ-stimulated 8-day-old
3D-organoids derived from NMuMG cells transfected as described in 3f from four biological replicates of the experiment, including the one shown in
3g (ANOVA: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001). i Representative ﬂuorescence microscopy scans of E-cadherin (E-cadherin antibody, red) and nuclear
(Hoechst 33258, blue) stained formalin-ﬁxed 8-day-old untreated or TGFβ-incubated 3D-organoids derived from NMuMG cells transfected and
subjected to three-dimensional culture as described and shown in 3f and 3g. Scale bar indicates 50 μm. TCF7L2 E2-1ir and E2-2ir inhibited, respectively,
the ability of TCF7L2 -1i and -2i to promote acini ﬁlling, deformation and loss/mislocalization of E-cadherin in the absence and presence of TGFβ.

expressed in HaCaT cells (Fig. 6b, c). Immunocytochemistry analyses revealed that TCF7L2 is predominantly nuclear, and that TGFβ drastically reduced
TCF7L2 in cells undergoing EMT (Fig. 6d). Similar to
NMuMG cells, immunoblotting analyses demonstrated
that TGFβ reduced the protein abundance of the TCF7L2
C-variant isoforms such that there was a signiﬁcant
reduction of the E to S/M isoform ratio (Fig. 6e, f). Next,
we established 3D cultures in which HaCaT cells organized into hollow-centered spherical multicellular structures, which were disrupted upon TGFβ treatment,
suggestive of induction of EMT-like effects (Figs. 6h, i and
S7A). Consistently, TGFβ promoted mislocalization and
reduction in the protein abundance of E-cadherin in the
3D-HaCaT-derived spheroids (Fig. 6j). Expression of
TCF7LE2 isoform suppressed, while that of S2 and M2,
promoted EMT-like behavior in the HaCaT-derived
spheroids, as indicated by ﬁlling and deformation, and
loss/mislocalization of E-cadherin in HaCaT cell-derived
spheroids (Figs. 6g–j and S7A). Knockdown of endogenous TCF7L2 promoted EMT-like characteristics, an effect
that was reversed by expression of shRNA2-resistant
rescue form of TCF7L2E2 (Figs. 6k–n and S7B). In contrast, knockdown of endogenous M2 or S2
TCF7L2 suppressed the ability of TGFβ to induce EMTlike changes in HaCaT cell-derived spheroids, which was
reversed by respective RNAi rescue TCF7L2 isoform
protein (Figs. 6k–n and S7B). Collectively, our data suggest that the regulation of TCF7L2 by TGFβ signaling
plays a critical role in EMT induction in epithelial cells.
Ofﬁcial journal of the Cell Death Differentiation Association

TCF7L2 acts via TGFβ signaling to regulate EMT and
organoid morphology

TGFβ activation of the signaling protein Smad3 mediates EMT induction in the 3D-epithelial cell-derived
acini27. We found that all C-variant isoforms of TCF7L2
associate with Smad3 in co-IP analyses (Fig. 7a). In other
studies, we conﬁrmed that knockdown of endogenous
Smad3 reversed TGFβ-induced EMT in 3D-NMuMG
cell-derived acini (Figs. 7b–e and S8A). Importantly,
Smad3 knockdown also reversed the ability of expressed
TCF7L2S2 isoform to promote EMT, suggesting that
TCF7L2S2 isoform may act upstream to promote the
ability of Smad3 to induce EMT (Figs. 7b–e and S8A). On
the other hand, EMT-like effects promoted by Smad3
expression were partially overcome by expression of
TCF7L2E2 (Figs. 7f–i and S8B). These data reveal that the
isoform-speciﬁc functions of TCF7L2 in EMT-like effect
in organoids are mediated by TGFβ-Smad3 signaling.
The transcriptional regulator SIP1 is induced by TGFβ
and is critical for induction of EMT, including by
repressing E-cadherin. Expression of TCF7L2E2 downregulated TGFβ-induced SIP1 mRNA expression in
NMuMG cells (Fig. 8a). We, therefore, tested if forced
expression of SIP1 opposes TCF7L2E2 to suppress
TGFβ-induced EMT. Expression of SIP1 promoted EMT
in NMuMG cell-derived acini even in the absence of
TGFβ (Figs. 8b–e and S9). However, TCF7L2E2 expression suppressed SIP1-induced EMT-like behavior (Figs.
8b–e and S9), suggesting that TCF7L2 may regulate EMT
by downregulating SIP1 mRNA levels and suppressing the
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Fig. 4 Endogenous M and S isoforms of TCF7L2 promote EMT in 3D-mammary epithelial cell-derived organoids. a–d Knockdown of
endogenous TCF7L2M2 suppresses TGFβ-induced EMT. a Lysates of NMuMG cells transfected with an RNAi vector control plasmid (−), or a TCF7LM2i
plasmid expressing shRNA against TCF7L2M2 (M2i), together with control vector (−) or a plasmid expressing a MYC/TCF7L2M2 protein that is sensitive
(+) or resistant (M2ir) to TCF7L2M2i, were subjected to MYC or actin immunoblotting, with the latter used as loading control. b Representative DIC
images of 8-day old untreated or TGFβ-stimulated 3D-organoids derived from NMuMG cells transfected as described in 4a. Green and red arrowheads
indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. c Bar graph of average percent (±SEM) of hollow acinar
untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected as described in 4a from three biological replicates of the
experiment, including the one shown in 4b (ANOVA: ***P ≤ 0.001). TCF7L2M2i reduced TGFβ-induced acini ﬁlling, which was reversed by expression of
the RNAi rescue protein TCF7L2M2-M2ir. d Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear(Hoechst 33258, blue) stained formalin-ﬁxed 8-day-old untreated or TGFβ-stimulated of 3D-organoids derived from NMuMG cells transfected and
subjected to three-dimensional culture as described and shown in 4a–b. Scale bar indicates 50 μm. Knockdown of endogenous TCF7L2M2 suppressed
reduction and mislocalization of E-cadherin by TGFβ, which was reversed by expression of the RNAi rescue protein TCF7L2M2-M2ir. e–h Knockdown of
endogenous TCF7L2S2 suppresses TGFβ-induced EMT. e Lysates of NMuMG cells transfected with an RNAi vector control plasmid (−), or a TCF7LS2i
plasmid expressing shRNA against TCF7L2S2 (S2i), together with a control vector (−) or a plasmid expressing a MYC/TCF7L2S2 protein that is sensitive
(+) or resistant (S2ir) to TCF7L2S2i, were subjected to MYC or actin immunoblotting, with the latter used as loading control. f Representative DIC
images of 8-day old untreated or TGFβ-stimulated 3D-organoids derived from NMuMG cells transfected as described in 4e. Green and red arrowheads
indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. g Bar graph of average percent (±SEM) of hollow acinar
untreated or TGFβ-stimulated 8-day old 3D-organoids derived from NMuMG cells transfected as described in 4e from three biological replicates of the
experiment, including the one shown in 4f (ANOVA: ***P ≤ 0.001). TCF7L2S2i reduced TGFβ-induced acini ﬁlling, which was reversed expression of the
RNAi rescue protein TCF7L2S2-S2ir. h Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear- (Hoechst
33258, blue) stained formalin-ﬁxed of untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected and subjected to
three-dimensional culture as described and shown in 4e–f. Scale bar indicates 50 μm. Knockdown of endogenous TCF7L2S2 suppressed reduction and
mislocalization of E-cadherin by TGFβ, which was reversed by expression of the RNAi rescue protein TCF7L2S2-S2ir.

ability of the protein SIP1 to regulate EMT-gene expression. Supporting the latter idea, we found that SIP1 and
TCF7L2E2 co-IP (Fig. 8f). Together, these data suggest
that TCF7L2E2 may suppress the ability of Smad3 and
SIP1 to regulate expression of EMT signature genes at
different levels.
Ofﬁcial journal of the Cell Death Differentiation Association

Collectively, our study reveals that TCF7L2E and
TCF7L2M/S isoforms suppress and promote, respectively,
TGFβ-induced EMT-like effects in 3D-epithelial-derived
organoids. Consistently, we ﬁnd that TGFβ reduces the E
to M/S protein isoform proportion in cells undergoing
EMT. Mechanistically, our studies suggest that the
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Fig. 5 (See legend on next page.)

TCF7L2E isoforms may suppress EMT at the level
TGFβ-Smad-SIP1 signaling axis.

Discussion
In this study, we have discovered novel isoform-speciﬁc
functions for the major transcription factor TCF7L2 and
identify novel links of TCF7L2 with TGFβ signaling in the
control of EMT and epithelial tissue morphogenesis. Our
data reveal that the C-variants TCF7L2 isoforms exert
Ofﬁcial journal of the Cell Death Differentiation Association

opposing functions in EMT regulation. Whereas,
TCF7L2E isoforms suppress, the TCF7L2S/M isoforms
promote EMT with consequences for 3D-epithelial cell
organoid’s morphogenesis. We have also found that
β-catenin signaling may not be needed for the C-variant
isoforms of TCF7L2 to regulate TGFβ-induced EMT. In
mechanistic studies, TGFβ signaling reduces the proportion of the TCF7L2E to TCF7L2S/M abundance. We have
found that TCF7L2E associates with Smad3 and the EMT
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(see ﬁgure on previous page)
Fig. 5 TGFβ downregulates the protein ratio of TCF7L2 E to M/S in mammary epithelial cells. a Representative ﬂuorescence microscopy scans of
TCF7L2- (TCF7L2 antibody, green) and nuclear-(Hoechst 33258, blue) stained formalin-ﬁxed subconﬂuent monolayers of NMuMG cells left untreated or
incubated with 100 pM TGFβ for 48 h. The images are from one of two biological replicates of the experiment. TCF7L2 localizes mainly in the nucleus.
TCF7L2 signal intensity was quantiﬁed using Image J software analyses. TGFβ led to an average of approximately 75% reduction in the protein abundance of
TCF7L2 in NMuMG cells undergoing EMT.b TGFβ signaling downregulates TCF7L2 transcript level. b Bar graph of average (±SEM) of relative GAPDHnormalized TCF7L2 mRNA determined by quantitative real time PCR (qRT-PCR) of cDNA derived from untreated or TGFβ-stimulated NMuMG cells from four
biological replicates of the experiment (ANOVA: ***P ≤ 0.001). c, d TGFβ reduces the protein proportion of E to S/M in NMuMG cells. c TCF7L2, pSmad2,
Smad2/3 and actin immunoblotting of lysates of NMuMG cells incubated with increasing concentrations of TGFβ for 48 h. d XY Plot of mean (±SEM) of the
protein abundance of E isoforms (violate-triangle and line), S/M-isoforms (golden-square and line), and protein ratio of E to S/M (blue-circle and line) (left Yaxis) and pSmad2 expressed relative to Smad2 (red-square and line) (right Y-axis) versus TGFβ concentration (X-axis) from six biological replicates of the
experiment, including the one shown in 5c (ANOVA: **P ≤ 0.01, ***P ≤ 0.001, as compared to respective untreated control). e, f TCF7L2 protein isoforms
proﬁling in NMuMG-derived organoids and effect of TGFβ stimulation. e TCF7L2, pSmad2, Smad2/3 and actin immunoblotting of lysates of 48h-monolayer
(2D) or 8-day organoid (3D) cultures of NMuMG cells left untreated or stimulated with TGFβ. f Bar graph of average (±SEM) of the protein ratio of E isoforms
to that of the M/S isoforms of TCF7L2 from four biological replicates of the experiment, including the one shown in 5e (ANOVA: ***P ≤ 0.001, as compared to
respective untreated control). g–i TCF7L2E2 and TCF7L2S2 coregulate morphogenesis of 3D-mammary epithelial cell-derived organoids. g Representative DIC
images of untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected as described in Fig. S6D. Green and red arrowheads
indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. h Bar graph of average percent (±SEM) of hollow acinar untreated or
TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected as in Fig. S6D from three biological replicates of the experiment, including
the one shown in 5g (ANOVA: ***P ≤ 0.001). i Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear- (Hoechst
33258, blue) stained formalin-ﬁxed untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected and subjected to threedimensional culture as described in Figs. S6D and 5G. Scale bar indicates 50 μm. j–m TCF7L2 isoforms form homo and hetero-oligomers in cells. Lysates of
293 T cells transfected with vector control or one expressing MYC/TCF7L2 E2 (J) or S2 (K) without (−) or with HA/TCF7L2E2 (+) (J and K) were subjected to
anti-HA immunoprecipitation (IP), followed by sequential MYC and HA immunoblotting. Lysates were also subjected to MYC, HA and actin immunoblotting,
with the latter used as loading control. TCF7L2E2 formed E2-homo-oligomers (j) and S2-hetero-oligomers (k). Representative scans are shown in each j and
k from one of two biological replicates of the experiment. Lysates of 293 T cells transfected with a plasmid-containing cDNA encoding the Renilla luciferase
protein (Rluc) alone (−) (l and m) or in fusion with TCF7L2E2 (E2) (l and m) or TCF7L2S2 (S2) (l), together with a vector control (−) or a plasmid expressing HA/
TCF7L2E2 (l) or HA/TCF7L2S2 (l and m), were anti-HA immunoprecipitated (α-HA-IP) followed by subjecting 90% of the immunocomplexes to Renilla
luciferase activity measurement (Luc assay) and the rest to anti-HA immunoblotting. 10% of each lysate was subjected to luciferase measurement as a relative
indicator of protein abundance of the luciferase gene product or input. Upper panels- bar graphs showing average (±SEM) input-normalized luciferase values
in the HA-immunocomplexes from three (l) and ﬁve (m) biological replicates of the experiment (ANOVA: ***P ≤ 0.001). Lower panels- HA immunoblot of the
HA immunoprecipitation from a representative biological replicate of the experiments shown in l and m.

driver SIP1 to suppress EMT. The TGFβ-Smad3-TCF7L2
isoform-speciﬁc signaling pathway uncovered here should
advance our understanding of mechanisms that regulate
development and diseases.
The opposing roles of the TCF7L2 isoforms in EMT
unraveled in this study add key insights into the biological
versatility of this transcription factor. TCF7L2 is implicated in regulating embryonic brain development and
maintenance of intestinal and breast-derived epithelial
tissues6,8,12,17. Deregulation of TCF7L2 may be involved in
diseases including multiple sclerosis, type II diabetes,
stroke, and cancer6,15,36–44. TCF7L2 has been suggested to
act as an oncogenic or tumor suppressor in colorectal and
breast carcinomas15,40–42,45. As EMT is key for proper
tissue and organ development, our ﬁndings provide an
important basis for future studies to characterize isoformspeciﬁc TCF7L2 roles in development and disease.
Our structure-function analyses point to a C-terminalcontaining region to be essential for the TCF7L2E isoforms to
maintain the epithelial phenotype in the face of TGFβ-induced
EMT. Several domains/motifs may contribute to the ability
TCF7L2E isoforms to suppress EMT as reﬂected by alignments of the divergent C-termini of TCF7L2, M and S protein
isoforms. In particular, a full C-clamp domain, the CtBPOfﬁcial journal of the Cell Death Differentiation Association

binding motifs, alone or together might contribute to the
ability of TCF7L2E isoforms to suppress EMT, as they are
absent in the M and S isoforms. As the E isoforms of TCF7
and TCF7L1 harbor a C-clamp domain and CtBP-binding
motifs, respectively, it will be interesting to determine if corresponding isoforms of these TCF/LEF members display differential biological effects including in EMT.
TCF7L2 has been largely suggested to mediate the
canonical Wnt-β-catenin signaling to regulate cellular
processes4,5. However, recent evidence suggests that
TCF7L2 may also act in Wnt signaling-independent
manner, for example in a bone morphogenetic protein
(BMP) signaling-dependent manner to promote oligodendrocyte differentiation4. Our ﬁndings that the
β-catenin-domain deletion does not inﬂuence the
isoform-speciﬁc TCF7L2-mediated responses, may provide further support for the idea that Wnt-β-catenin signaling may not regulate TCF7L2 role in EMT, with
potential signiﬁcance to in vivo processes. Identiﬁcation
of EMT-gene signature candidates and their responsive
elements that are differentially regulated by the E vs S/M
TCF7L2 isoforms can address whether regulation of
β-catenin-responsive elements in these genes contributes
to the isoform-speciﬁc function of TCF7L2 in EMT.
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Fig. 6 (See legend on next page.)

Our novel ﬁnding that TCF7L2 functions in TGFβ
signaling and potentially independently of β-catenin signaling has raised several key questions. What are the
implications for other TGFβ responses? Might TCF7L2 be
relevant for other TGFβ outcomes besides EMT-like
effects? Likewise, might TCF7L2 functions in other biological responses be subject to TGFβ signaling regulation?
Our mechanistic studies provide a model in which
TCF7L2E/S/M associates with Smad3 potentially via a
common domain/motif including on promoters of
TGFβ-responsive genes with implications for EMT induction5,46,47. Supporting this idea is our ﬁnding that
TCF7L2E2 suppresses TGFβ-induced expression of the
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major EMT driver SIP127,48. Further, our novel ﬁnding that
TCF7L2 isoforms form homo-, and hetero-oligomers suggests the possibility that these complexes may have a role in
regulating EMT-like responses, and thus adds complexity to
the mechanisms in control of this key process.
In conclusion, our data suggest a model where the
cellular level of TCF7L2E isoforms controls the ability of
cells to maintain an epithelial phenotype under condition
of no/low TGFβ signaling, and where increased TGFβ
signaling triggers events that reduces the proportion of
TCF7L2E to M/S isoforms that leads to cells undergoing
EMT. These ﬁndings add insight into the regulation of
EMT-like effects including in development and diseases.
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(see ﬁgure on previous page)
Fig. 6 TGFβ-TCF7L2 isoform-speciﬁc signaling regulates EMT in three-dimensional skin epithelial cell-derived organoids. a Representative
DIC scans of subconﬂuent monolayers of the human skin keratinocytes HaCaT cells left untreated or incubated with 100 pM TGFβ for 48 h. The scans
are from one of three biological replicates of the experiment. Cuboidal-shaped HaCaT cells undergo EMT to form elongated spindle-shaped
mesenchymal cell morphology. b Polyacrylamide gel resolved and stained C-variant TCF7L2 mRNA fragments ampliﬁed from HaCaT cDNA using S10f
and S17r oligonucleotides (Table 1). c Lysates of HaCaT cells were subjected to immunoprecipitation (IP) using a mouse IgG or a mouse antibody
recognizing the N-terminus of TCF7L2 followed by immunoblotting of the immunocomplexes and total lysates with a rabbit anti-TCF7L2 antibody
(see Fig. S1A). TCF7L2 protein species with apparent molecular mass of ~75 kDa (E isoforms) and 60 (M/S isoforms) kDa were detected in the αTCF7L2 immunoblotting of α-TCF7L2-immunocomplexes and lysates. d Representative ﬂuorescence microscopy scans of TCF7L2- (TCF7L2 antibody,
green) and nuclear-(Hoechst 33258, blue) stained formalin-ﬁxed subconﬂuent monolayers of HaCaT cells left untreated or incubated with 100 pM
TGFβ for 48 h. TGFβ led to approximately 80% reduction in total TCF7L2 isoforms in HaCaT cells undergoing EMT. The scans are from one of two
biological replicates of the experiment. e–f TGFβ reduces the protein ratio of TCF7L2E to TCF7L2M/S in HaCaT cells. (e) TCF7L2, pSmad2, Smad2/3
and actin immunoblotting of lysates of HaCaT cells incubated without or with 100 pM TGFβ, alone or together with 10 µM KI for 48 h. f Bar graph
mean (±SEM) protein ratio of E to M/S (Y-axis) versus incubation (X-axis) for experiments as described and assessed in 6e from three biological
replicates of the experiment (ANOVA: ***P ≤ 0.001). g–j TCF7L2E2 suppresses, while TCF7L2M2/S2 promotes EMT induction in three-dimensional skin
epithelial cell-derived spheroids. g Lysates of HaCaT cells transfected with the vector control or a plasmid-containing cDNA encoding MYC/TCF7L2E2
(E2), MYC/TCF7L2M2 (M2), or MYC/TCF7L2S2 (S2), were subjected to immunoblotting with MYC or actin antibody, with the latter used as loading
control. h Representative DIC images of 8-day-old untreated or TGFβ-stimulated 3D-spheroids derived from HaCaT cells transfected as described in
6g. Green and red arrowheads indicate hollow center and ﬁlled/deformed spheroids, respectively. Scale bar indicates 50 μm. i Bar graph of average
percent (±SEM) of hollow acinar untreated or TGFβ-stimulated 8-day-old spheroids derived from HaCaT cells transfected as in 6g from three
biological replicates of the experiment, including the one shown in 6H (ANOVA: **P ≤ 0.01, ***P ≤ 0.001). TCF7L2E2 suppressed the ability of TGFβ to
promote spheroid ﬁlling of HaCaT cell-derived spheroids. TCF7L2M2/S2 promoted spheroid ﬁlling even in the absence of TGFβ. j Representative
ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear- (Hoechst 33258, blue) stained formalin-ﬁxed untreated or
TGFβ-stimulated 8-day-old 3D-spheroids derived from HaCaT cells transfected and subjected to three-dimensional culture as described in 6G-6I. Scale
bar indicates 50 μm. TCF7L2E2 suppressed TGFβ‘s ability to decrease the protein abundance and/or mislocalization of E-cadherin, while TCF7L2M2/S2
promoted loss and mislocalization of E-cadherin even in the absence of TGFβ. k–n Endogenous TCF7L2 act in an isoform-dependent manner to
regulate EMT in 3D-skin epithelial cell-derived spheroids. k Lysates of HaCaT cells transfected with a pU6 RNAi vector control plasmid (−), or one
expressing the pan TCF7L2-2i (2i), or the isoform-speciﬁc TCF7L2S2i (S2i) or TCF7L2M2i (M2i) shRNAs, together with a vector control (−) or a plasmid
expressing a MYC/TCF7L2 E2-2ir, S2-ir, or M2ir that is resistant to knockdown by TCF7L2- 2i, -S2i, or -M2i, respectively, were subjected to anti-MYC and
anti-actin immunoblotting, with the latter used as loading control. l Representative DIC images of 8-day old untreated or TGFβ-stimulated 3Dspheroids derived from HaCaT cells transfected as described in 6k. Green and red arrowheads indicate hollow center and ﬁlled/deformed spheroids,
respectively. Scale bar indicates 50 μm. m Bar graph of average percent (±SEM) of hollow- lumen untreated or TGFβ-stimulated 8-day-old 3Dspheroids derived from HaCaT cells transfected as described in 6k from three biological replicates of the experiment, including the one shown in 6l
(ANOVA: ***P ≤ 0.001). Knockdown of endogenous TCF7L2 by TCF7L2-2i promoted hollow-lumen ﬁlling of spheroids even in the absence of TGFβ,
which was reversed by TCF7L2E2-2ir. TCF7L2-S2i, and TCF7L2-M2i reduced TGFβ-induced ﬁlling of the hollow-lumen spheroids, which were reversed
by the expression of the proteins TCF7L2S2-S2ir and TCF7L2M2-M2ir, respectively. n Representative ﬂuorescence microscopy scans of E-cadherin- (Ecadherin antibody, red) and nuclear- (Hoechst 33258, blue) stained formalin-ﬁxed untreated or TGFβ-stimulated of 8-day old 3D-spheroids derived
from HaCaT cells transfected as described and subjected to three-dimensional culture in 6K-6M. Scale bar indicates 50 μm. Endogenous TCF7L2
knockdown by TCF7L2-2i reduced the protein abundance and led to mislocalization of E-cadherin even in the absence of TGFβ, which were reversed
by TCF7L2E2-2ir. TCF7L2 knockdown by TCF7L2S2i and TCF7L2M2i suppressed the ability of TGFβ to reduce and mislocalize E-cadherin, which were
reversed by the rescue proteins TCF7L2S2-S2ir and TCF7L2M2-M2ir, respectively.

Materials and methods
Plasmids

pCMV5B, a cytomegalovirus (CMV)-based mammalian
expression plasmid, containing cDNA encoding MYCtagged mouse TCF7L2E2 with (MYC/TCF7L2E2ex4) or
without (MYC/TCF7L2E2) exon 4 was generated using a
conventional molecular biology cloning strategy as follows. DNase-treated TRIzol (Ambion, Life technologies)NMuMG cells-extracted RNA was reverse transcribed
using SuperScript II transcriptase (Invitrogen) and oligo(dT)12-18 (Amersham Biosciences)49. The polyA-cDNA
was subjected to PCR ampliﬁcation of the TCF7L2E isoforms open reading frame using the forward E1f and
reverse E17r-i oligonucleotides (Table 1), and subcloning
into pCMV5B/MYC using convenient restriction sites. To
generate pCMV5B/MYC/TCF7L2E3, E4, M1, M2, or S2,
NMuMG-derived polyA-cDNA was subjected to PCR
Ofﬁcial journal of the Cell Death Differentiation Association

ampliﬁcation using as forward E12f and reverse E17r-ii
oligonucleotides (Table 1) corresponding to exons 12, and
17, respectively, followed by 10% polyacrylamide gelseparation, puriﬁcation (Qiagen gel extraction Kit (Qiagen)), sequencing, and subcloning of respective C-variant
fragment into restriction endonuclease digested
pCMV5B/MYC/TCF7L2E2 replacing the E2- C-variant
fragment. To generate a β-catenin binding domain (ΔN)deleted TCF7L2 expression vector, TCF7L2 was subjected
to PCR ampliﬁcation by forward E2f and reverse E6r
oligonucleotides (Table 1), and subcloned into a digested
pCMV5B/MYC/TCF7L2E2, M2 or S2 plasmid using
convenient restriction sites. Hemagglutinin (HA)- tagged
TCF7L2E2, HA/TCF7L2M2 or HA/TCF7L2S2 were
generated by subcloning the corresponding TCF7L2 isoform into pCMV5B/HA expression vector. To establish
NMuMG stable cell lines, a pCAGIP vector was employed
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Fig. 7 (See legend on next page.)

Ofﬁcial journal of the Cell Death Differentiation Association

Page 14 of 20

Karve et al. Cell Death and Disease (2020)11:704

Page 15 of 20
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Fig. 7 TGFβ-Smad3-TCF7L2 isoform-speciﬁc signaling regulates EMT and acini morphology. a Lysates of 293 T cells cotransfected with a
plasmid-containing cDNA encoding the Renilla luciferase protein alone (−) or in fusion with TCF7L2 E2, M2, or S2, together with a vector control or a
plasmid expressing FLAG/Smad3, were Smad3 immunoprecipitated (α-FLAG IP) followed by luciferase assay on 90% of the immunocomplexes, with
the rest subjected to Smad3 immunoblotting (anti-FLAG IB). 10% of each lysate was subjected to luciferase as a measure of relative input. Upper
panel—bar graph shows average (±SEM) input-normalized Smad3 immunocomplexes-containing luciferase values from ten biological replicates of
the experiment (ANOVA: ***P ≤ 0.001). Lower panel—Smad3 level in the Smad3 immunocomplexes from a representative of ten biological replicates
of the experiment, assessed as in 7a. Smad3 interacts with the TCF7L2 C-variants. b–e Endogenous Smad3 promotes TCF7L2S2-induced EMT of 3DNMuMG cell-derived organoids. b Lysates of NMuMG cells transfected with vector control or MYC/TCF7L2S2 with a pU6 RNAi control vector (−) or
one expressing Smad3 shRNAs (Smad3i), were subjected to MYC, Smad2/3, or actin immunoblotting, with the latter used as loading control.
c Representative DIC images of 8-day old untreated or TGFβ-stimulated 3D-organoids derived from NMuMG cells transfected as described in 7b.
Green and red arrowheads indicate hollow center and ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. d Bar graph of average percent
(±SEM) of hollow acinar untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected as in 7b from three biological
replicates of the experiment, including the one shown in 7c (ANOVA: ***P ≤ 0.001). e Representative ﬂuorescence microscopy scans of E-cadherin- (Ecadherin antibody, red) and nuclear- (Hoechst 33258, blue) stained formalin-ﬁxed untreated or TGFβ-treated 8-day old 3D-organoids derived from
NMuMG cells transfected and subjected to three-dimensional culture as described and shown in 7b and 7c. Knockdown of endogenous
Smad3 suppressed the ability of TCF7L2S2 to induce EMT. f–i TCF7LE2 and Smad3 functionally interact to regulate EMT. f Lysates of NMuMG cells
transfected with vector control or a MYC/TCF7L2E2 expressing plasmid, in absence or presence of FLAG/Smad3, were subjected to MYC, FLAG, or
actin immunoblotting, with the latter used as a loading control. g Representative DIC images of untreated or TGFβ-stimulated 8-day-old 3Dorganoids derived from NMuMG cells transfected as described in 7f. Green and red arrowheads indicate hollow center and ﬁlled/deformed acini,
respectively. Scale bar indicates 50 μm. h Bar graph of average percent (±SEM) of hollow acinar untreated or TGFβ-stimulated 8-day-old 3D-organoids
derived from NMuMG cells transfected as in 7f from three biological replicates of the experiment, including the one shown in 7g (ANOVA: ***P ≤
0.001). i Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear- (Hoechst 33258, blue) stained formalinﬁxed untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected and subjected to three-dimensional culture as
described and shown in 7f and 7g. Scale bar indicates 50 μm.

to generate constructs containing cDNA encoding MYC/
TCF7L2E2, with the cDNA encoding TCF7L2 and the
puromycin resistance marker driven by the upstream
promoter to generate a bicistronic transcript with Internal
Ribosomal Entry Site (IRES) leading to express TCF7L2
and resistance marker proteins50. Expression plasmids
containing cDNA encoding U6 promoter-based control
RNAi vector, coexpressing enhanced green ﬂuorescent
protein (EGFP) under the control of a CMV promoter,
was used to generate TCF7L2 pan RNAi plasmids RNA-1i
and RNA-2i containing double stranded DNA encoding
short hairpin (sh) RNA1, shRNA2 to target nucleotides
common to all TCF7L2 isoforms (Table 2). The RNAi
plasmids RNA-M2i and RNA-S2i encoding the expression
of TCF7L2 shRNA-M2i and shRNA-S2i were generated
to selectively knockdown the TCF7L2M2 and TCF7L2S2
isoforms, respectively (Table 2)50,51. Expression RNAi
rescue constructs were generated encoding the following
RNAi-resistant TCF7L2 protein isoform: E2, M2, or S2
RNA-1i rescue (E2-1ir, M2-1ir, or S2-1ir), E2 RNA-2irescue (E2-2ir), M2 RNA-M2i rescue (M2ir), and S2
RNA-S2i rescue (S2ir), by changing the TCF7L2 cDNA at
the nucleotide level, while keeping the amino acid
sequence intact, in the region targeted by the speciﬁc
TCF7L2 RNAi plasmid. Plasmids were validated by DNA
sequence analyses (University of Calgary Core Sequencing
Facility, Calgary, AB, Canada). FLAG/Smad3 and green
ﬂuorescent protein (GFP)/Smad Interacting Protein 1
(SIP1) have been described52.
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Cell lines and transfections

The NAMRU mouse mammary gland epithelial cells
(NMuMG) (American Type Culture Collection (ATCC),
Cat # CRL-1636) were maintained in Dulbecco’s modiﬁed
Eagle’s medium with high glucose and L-glutamine
(Invitrogen), supplemented with 10 mg/ml insulin (Invitrogen, cat # 12585-014) and 10% fetal bovine serum. A
human adult keratinocyte cell line (HaCaT)53,54 were
cultured in Dulbecco’s modiﬁed Eagle’s medium containing 10% FBS (FBS, Gibco, Cat # 12483-020). Human
embryonic kidney epithelial 293 T cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium with high glucose
and L-glutamine supplemented with 10% fetal bovine
serum. All the cells were conﬁrmed to be free of pathogenic Mycoplasma strains by a PCR-ELISA kit (Roche,
Cat # 11663925910). The 293 T cells were transiently
transfected using the calcium phosphate precipitation
method, and NMuMG and HaCaT cells were transfected
using Lipofectamine LTX Plus reagents (Thermo Fisher
Scientiﬁc, Cat # 15338100).
Co-immunoprecipitation and immunoblotting

Non-transfected or transfected cells of monolayer cultures were washed with 1X phosphate-buffered saline
(PBS), followed by incubation with 1X TNE (pH 7.3) lysis
buffer (50 mM Tris, 150 mM NaCl, and 1 mM EDTA and
0.5% Triton X-100), containing trypsin inhibitors, protease inhibitors, pepstatin A and Phenyl methane sulfonyl
Fluoride (PMSF) as protease inhibitors and sodium
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Fig. 8 SIP1/Zeb2 contributes to TCF7L2E2 regulation of EMT. a TCF7L2E2 expression suppresses TGFβ-induced SIP1/Zeb2 mRNA expression.
cDNA derived from untreated or TGFβ-stimulated vector control or TCF7L2E2-stably expressing NMuMG cells was subjected to SIP1/Zeb2 and
GAPDH real time PCR assessment, with two technical repeats for each measurement per biological replicate of the experiment. The values from
technical repeated were averaged for each measurement per biological repeat. Bar graph shows average (±SEM) of GAPDH-normalized SIP1/Zeb2
mRNA in untreated or TGFβ-stimulated control and TCF7L2E2 expressing NMuMG cells relative to that in the untreated control from seven biological
replicates of the experiment, (ANOVA: ***P ≤ 0.001). b–e TCF7L2E2 -SIP1/Zeb2 interplay and EMT control. b Lysates of NMuMG cells transfected with
vector control (−) or MYC/TCF7L2E2 (+) together with a plasmid expressing the green ﬂuorescent protein (GFP) alone (+) or in fusion with SIP1,
were subjected to MYC, GFP, or actin immunoblotting, with the latter used as loading control. c Representative DIC images of 8-day-old untreated or
TGFβ-stimulated 3D-organoids derived from NMuMG cells transfected as described in 8b. Green and red arrowheads indicate hollow center and
ﬁlled/deformed acini, respectively. Scale bar indicates 50 μm. d Bar graph of average percent (±SEM) of hollow acinar untreated or TGFβ-stimulated 8day-old 3D-organoids derived from NMuMG cells transfected as in 8b from ﬁve biological replicates of the experiment, including the one shown in
8c (ANOVA: ***P ≤ 0.001). e Representative ﬂuorescence microscopy scans of E-cadherin- (E-cadherin antibody, red) and nuclear- (Hoechst 33258,
blue) stained formalin-ﬁxed untreated or TGFβ-stimulated 8-day-old 3D-organoids derived from NMuMG cells transfected and subjected to threedimensional culture as described and shown in 8b and 8c. Scale bar indicates 50 μm. f Lysates of 293 T cells transfected with a plasmid-containing
cDNA encoding the Renilla luciferase protein (Rluc) alone (+) or in fusion with TCF7L2E2 together with a plasmid expressing the GFP alone (+) or in
fusion with SIP1, were immunoprecipitated with an anti-SIP1 or IgG antibody followed by luciferase assay and SIP1 immunoblotting of 90% and 10%,
respectively, of the immunocomplexes. For each transfection, 10% of the lysates was subjected to luciferase assays as a measure of relative input.
Upper panel—bar graph shows average (±SEM) input-normalized luciferase values in the IgG-subtracted SIP1 immunocomplexes from four
biological replicates of the experiment (ANOVA: *P ≤ 0.05, ***P ≤ 0.001). Lower panel—SIP1 immunoblot of the SIP1 immunocomplexes from of a
representative of the four biological replicates of the experiment. Blue asterisk and red asterisk indicate endogenous and expressed SIP1 protein,
respectively. SIP1 and TCF7LE2 associate.

ﬂuoride, sodium pyrophosphate and sodium vanadate as
phosphatase inhibitors for 20 min at 4 °C. Cellular extracts
were collected into 1.75 ml Eppendorf tubes and centrifuged at 14,000 rpm for 10 min at 4 °C in Sigma centrifuge. Approximately 90% of the cell lysates’
supernatants were collected and subjected to mouse
TCF7L2 (Millipore, cat # 6H5-3) or control IgG (SantaCruz, cat # sc-2025) or rabbit TCF7L2 (cell signaling, cat #
C48H11) or control IgG (Santa-Cruz, cat # sc-2027), or
mouse anti-HA (Biolegend, Cat # 901515) immunoprecipitation at 4 °C. The remaining 10% of the supernatants
were used for protein quantiﬁcation (Bradford protein
assay/spectroscopic analysis procedure, Biorad Cat # 5000006) and determining the abundance of speciﬁc proteins
by immunoblotting. Proteins in the supernatants and
immunoprecipitations were resolved by sodium dodecyl
Ofﬁcial journal of the Cell Death Differentiation Association

sulfate- polyacrylamide gel electrophoresis (SDS-PAGE),
followed by transfer to nitrocellulose membranes (Biorad,
Cat # 1620115), and probing using mouse anti-TCF7L2
(Millipore, Cat #6H5-3), rabbit anti-TCF7L2 (Cell Signaling technology, Cat # C48H11), mouse anti-HA (Biolegend, Cat # 901515), mouse anti-MYC (Santa-Cruz, Cat
# sc-40), mouse anti-FLAG (Sigma, Cat # F1804-5MG), or
mouse anti-actin (Santa-Cruz, Cat # sc-47778) as primary
antibodies and HRP-conjugated goat anti-mouse or donkey anti-rabbit IgG (Jackson Laboratories) as secondary
antibodies, followed by incubation in Enhanced Chemiluminescence (ECL) (Millipore Cat # WBLUR0500)
reagent. Chemi-luminescence light signal detection was
done using VersaDoc 5000 Imaging system and densitometry was performed using Quantity One software (BioRad Laboratories).
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Table 1 Oligonucleotide related information.
List and name

sequence (5’ →3’)

E1f

GGCGTCGACAACCGCAGCTGAACGGCGGTGG

E17r-i

CCGTCTAGACTATTCTAAAGACTTGGTCACCAGAGACAG

E12f

ACAAGCAGCCGGGGGAAAC

E17r-ii

AGCCTAGCAGATGCGGTGAG

E2f

GGCGTCGACAAACGAATCAAAACAGCTCCTCCG

E6r

TTCCTGTTTTGGGGTCTACG

E10f

CTGAGTGCACGTTGAAAGAAAG

q-TCF7L2-f

CCGAATGCACATTGAAAGAGAG

q-TCF7L2-r

GGGCCAGCTCGTAGTATTT

q-SIP1-f

CTCATTCTGGGTCCTACAGTTC

q-SIP1-r

GGGAAGAACCCGTCTTGATATT

q-E-cad-f

CTGCTGCTCCTACTGTTTCTAC

q-E-cad-r

TCTTCTTCTCCACCTCCTTCT

q-GAP-f

TCAACAGCAACTCCCACTCTTCCA

q-GAP-r

ACCCTGTTGCTGTAGCCGTATTCA

target sequence in mouse

No. of mismatches

(5’ →3’)

in human

TCF7L2-1i

GCACACATCGTTTCGAACAAA

2

TCF7L2-2i

GTACAGCAATGAACACTTCA

0

TCF7L2-M2i

CCTCCGATCACAGGAGAAA

1

TCF7L2-S2i

CCCTGCAGATGCAAATACGC

2

Smad3i

GTGCGAGAAGGCGGTCAAGAG

0

Renilla luciferase (Rluc)-based assessment of coimmunoprecipitating Rluc only (control) or Rluc/
TCF7L2 protein involved subjecting 90% of a given
immunoprecipitation resuspended in 50 ul 0.1% Triton X100-containing TNE buffer to luciferase assay (Luc assay).
The remaining 10% of the immunocomplexes were subjected to immunoblotting to conﬁrm the presence of an
immunoprecipitated protein. For each transfection per
biological replicate, 10% of the lysate was subjected to
luciferase measurement as the “input” for the Rluc or
Rluc/TCF7L2 protein in a given immunoprecipitation.
Renilla luciferase values were obtained using the Renilla
luciferase kit (Promega kit) coupled to the Orion II
luminometer (Titertek–Berthold) detection system. For
each transfection in a biological replicate per experiment,
input-normalized coimmunoprecipitated Rluc value was
Ofﬁcial journal of the Cell Death Differentiation Association

expressed relative to the biological replicate’s global
average and subjected to statistical analysis, followed by
expression relative to the corresponding value of the Rluc
only control, and plotting as mean ± SEM of the biological
replicates of given experiment as a bar graph.
In case of the lysing of three-dimensional cell-derived
multicellular structures, cell cultures were subjected to
vigorous up and down pipetted to help dislodge the
colonies form the Matrigel-based ECM. Cell-Matrigel
mixtures from several technical replicates per condition of
a biological replicate were pooled in ice-cold serum-free
DMEM followed by resuspension of the mixture using a
pipet to isolate cellular aggregates from the Matrigel. The
isolated cell suspensions were centrifuged at 1500 rpm for
5 min, and pellets were washed once with 1X PBS and
lysed as described in the cell lysis procedure for monolayer cultures, and lysates were subjected to immunoblotting as described.
Generation and analyses of three-dimensional epithelial
cell-derived multicellular structures

Table 2 RNAi plasmids related information.
Name
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Epithelial cells were trypsinized and used for the generation of three-dimensional cultures26,27. Seventy-ﬁve
microliter of ice-cold 30% growth factor-reduced Matrigel
(Corning, Cat # 354230) solution (3 mg/ml ﬁnal concentration) in growth medium containing antibiotics and
antimitotic agents (complete medium) was added to a
low-attachment well of an 8-well chamber slides (Millipore, Cat # PEZGS0816). The chamber slides were kept at
37 °C in a 5% CO2 incubator for 1 h to allow the setting of
Matrigel cushions. Next, a mixture of ~800 epithelial cells
in 75 ul of ice-cold 50% growth factor-reduced Matrigel
solution (5 mg/ml ﬁnal concentration of the Matrigel) in
complete medium was carefully layered on top of the
Matrigel cushion in each well of the 8-well chambers.
100 μL of complete medium was layered on top 1 h later,
and the cultures were kept in a controlled 5% CO2
humidiﬁed incubator at 37 °C. The next day, the threedimensional cell cultures were incubated in the absence
or presence of 20 pM TGFβ, or 10 µM of the TGFβ type I
receptor ser/thr kinase small molecule inhibitor SB431542
(KI for short-Figs. 2 and 3) in a 5% CO2 humidiﬁed
incubator at 37 °C. 8-day-old three-dimensional epithelial
cell-derived multicellular structures or “organoids”, a total
of ~30–40, were visualized by light microscopy and qualitatively assessed for (a) hollow vs ﬁlled acini and (b)
organized vs deformed morphology, before capturing the
images of 8–10 randomly selected organoids using Differential Interference Contrast (DIC) microscopy with an
inverted microscope at a ×20 objective lens for presentation and quantitative analyses (Olympus IX70,
Olympus Canada Inc) (see below). The multicellular
structures were then ﬁxed with 4% formaldehyde, followed by permeabilization using 0.5% cold Triton X-100

Karve et al. Cell Death and Disease (2020)11:704

solution and blocking using 5% BSA in phosphatebuffered saline. The multicellular structures or organoids were subjected to immunocytochemical analyses
using a rabbit E-cadherin antibody (Cell Signaling Technology, Cat # 3195) as the primary antibody and Cy5conjugated anti-rabbit IgG (Jackson Lab, Burlington, ON,
Canada) as the secondary antibody along with the DNA
dye bisbenzimide (Hoechst 33258, Invitrogen) to visualize
nuclei. Immunoﬂuorescent images of the multicellular
colonies were captured using a ﬂuorescent microscope
with a ×40 objective lens (Olympus IX70, Olympus
Canada Inc). Exposure times for E-cadherin and Hoechstspeciﬁc signals were kept constant in each biological
replicate of a given experiment. For morphological analyses of the organoids imaged using DIC microscopy, for
each experimental condition, the multicellular structures
were scored for (1) presence or absence of hollow lumen,
and (2) presence or absence of deformation including
budding and invasive morphological characteristics. The
data were plotted as bar graphs versus experimental
condition and statistically analyzed as described in the
ﬁgure legends and under the statistical analyses section.
Indirect immunoﬂuorescence

Eight-well chamber-slide-seeded epithelial NMuMG or
HaCaT cells were subjected to indirect immunoﬂuorescence as described55. Brieﬂy, the epithelial cells
were ﬁxed with 4% formaldehyde (Thermo Fisher,
Canada), permeabilized with 0.2% Triton-X-100, and
blocked using 5% bovine serum albumin (BSA, Sigma)
and 5% calf serum (VWR, Canada) in phosphate-buffered
saline (PBS). Subcellular localization and abundance of
TCF7L2 were determined by incubating NMuMG cells
with a mouse anti-TCF7L2 antibody (Millipore, Cat #
6H5-3) followed by Cy2-conjugated anti-mouse IgG
(Jackson Lab, Burlington, ON, Canada) using a wellestablished protocol55. Cells were incubated with the
DNA ﬂuorescent dye Hoechst 33342 (Invitrogen) to
visualize their nuclei. Immunoﬂuorescent images of cells
were captured using a ﬂuorescence microscope with a 40
X objective lens (Olympus IX70). For each experiment
and each ﬂuorophore, the exposure time was kept constant. The pixel signal intensity for TCF7L2 immunoﬂuorescence for all cells in three to four ﬁelds for each
treatment condition was quantiﬁed using ImageJ software
(NIH, Bethesda). The percent change in the TCF7L2 pixel
signal intensity by TGFβ as compared to the untreated
cells was determined and expressed as mean (±SEM) from
two independent biological replicates.
RT- PCR

DNase-treated TRIzol (Gibco)-extracted RNA from
NMuMG or HaCaT cells was reverse transcribed using
SuperScript II transcriptase (Invitrogen) and oligo- (dT)
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12-18 (Amersham Biosciences)26. The polyA-cDNA was
subjected to PCR ampliﬁcation using Taq DNA polymerase (NEB, Cat # M0267L), together with the TCF7L2
forward primer E12f (NMuMG) or E10f (HaCaT) and the
reverse conserved primer E17r-ii, with the two primer sets
ﬂanking a region between exons 12 and 17 or 10 and 17,
respectively. (Table 1). The PCR products were resolved
using 10% polyacrylamide gel electrophoresis, stained with
redsafe dye at 1:20,000 (iNtRON biotechnology inc), and
visualized and imaged using VersaDoc 5000 Imaging system to ascertain the C-terminal variants of TCF7L2 cells.
Quantitative reverse transcription (RT)-PCR

RNA extracted from NMuMG cells using DNase-treated
TRIzol (Gibco, Cat # 15596026) was reverse transcribed
using SuperScript II transcriptase (Invitrogen, Cat #
18064014) and oligo- (dT)12-18 (Invitrogen, Cat #
18418012)26. The cDNAs were subjected to quantitative PCR
of the following genes: TCF7L2: forward q-TCF7L2-f, reverse
q-TCF7L2-r; SIP1: forward q-SIP1-f, reverse q-SIP1-r; and Ecadherin: forward q-E-cad-f, reverse q-E-cad-r (Table 1), and
as a house-keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH): forward q-GAP-f, reverse q-GAP-r
(Table 1), employed as an internal control, using a 2X Sybr
Green Mix (BioRad, Cat # 1725272) and Rotor-Gene Thermocycler (Corbett Research). The speciﬁcity of the ampliﬁcation products was conﬁrmed using the melting curve
method. Data were analyzed and expressed as described26,56.
The 2–ΔΔCt method was used to determine the GAPDHnormalized expression of a gene of interest and expressed
relative to the experimental control condition. Each condition per biological replicate per experiment was repeated
twice, and values averaged for obtaining the mean of the
biological replicates.
Statistical analyses

Number and type of replicates, i.e., biological versus
technical repeats, are indicated in the legends of Figs. 1–8.
The term “biological replication” in this study refers to the
use of a distinct source of cultured cells for the various
tested parameters per replicate for a given experiment.
Thus, the replicates are performed in an independent
manner. The term “technical replication” refers to subjecting the same sample to repeated measurement. Data
from experiments carried out using biological replicates
were subjected to statistical analysis by t-test or ANOVA
followed by Student–Newman–Keuls test (InStat, San
Diego, CA, USA). Values of P < 0.05 were considered
statistically signiﬁcant. Single, double and triple asterisks
(*, **, and ***) denote signiﬁcance at P ≤ 0.05, P ≤ 0.01, and
P ≤ 0.001, respectively. Data are presented graphically as
mean ± standard error of the mean (SEM) of biological
replicates that were performed at least three independent
times for a given experiment.

Karve et al. Cell Death and Disease (2020)11:704

Acknowledgements
We would like to thank Dr. Derrick Rancourt and Dr. Donna Senger for use of
their Olympus IX70 ﬂuorescence microscopes. This work was supported by
grants from the Natural Sciences and Engineering Research Council of Canada
(NSERC), the Canadian Cancer Society (CCS), and the Calgary Centre for Cancer
Research (CCCR) to S.B. K.K. is a recipient of a University of Calgary Doctoral
Scholarship.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.

Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Supplementary Information accompanies this paper at (https://doi.org/
10.1038/s41419-020-02905-z).
Received: 16 December 2019 Revised: 4 August 2020 Accepted: 4 August
2020

References
1. Baralle, F. E. & Giudice, J. Alternative splicing as a regulator of development
and tissue identity. Nat. Rev. Mol. Cell Biol. 18, 437–451 (2017).
2. Castrop, J., van Norren, K. & Clevers, H. A gene family of HMG-box
transcription factors with homology to TCF-1. Nucleic Acids Res. 20,
611 (1992).
3. Weise, A. et al. Alternative splicing of Tcf7l2 transcripts generates
protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets. Nucleic Acids Res. 38, 1964–1981
(2010).
4. Hammond, E. et al. The Wnt effector transcription factor 7-like 2 positively
regulates oligodendrocyte differentiation in a manner independent of Wnt/
beta-catenin signaling. J. Neurosci. 35, 5007–5022 (2015).
5. Nakano, N., Kato, M. & Itoh, S. Regulation of the TMEPAI promoter by TCF7L2:
the C-terminal tail of TCF7L2 is essential to activate the TMEPAI gene. J.
Biochem. 159, 27–30 (2016).
6. Howng, S. L. et al. Differential expression and splicing isoform analysis of
human Tcf-4 transcription factor in brain tumors. Int. J. Oncol. 25, 1685–1692
(2004).
7. Hoppler, S. & Kavanagh, C. L. Wnt signalling: variety at the core. J. Cell Sci. 120,
385–393 (2007).
8. Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small
intestine of mice lacking Tcf-4. Nat. Genet. 19, 379–383 (1998).
9. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 127,
469–480 (2006).
10. Vacik, T. & Lemke, G. Dominant-negative isoforms of Tcf/Lef proteins in
development and disease. Cell Cycle 10, 4199–4200 (2011).
11. Ravindranath, A. J. & Cadigan, K. M. The role of the C-clamp in Wnt-related
colorectal cancers. Cancers 8, 1–12 (2016).
12. Nagalski, A. et al. Postnatal isoform switch and protein localization of LEF1
and TCF7L2 transcription factors in cortical, thalamic, and mesencephalic
regions of the adult mouse brain. Brain Struct. Funct. 218, 1531–1549
(2013).
13. Duval, A. et al. The human T-cell transcription factor-4 gene: structure,
extensive characterization of alternative splicings, and mutational analysis in
colorectal cancer cell lines. Cancer Res. 60, 3872–3879 (2000).
14. Arias, A. M., Brown, A. M. & Brennan, K. Wnt signalling: pathway or network?
Curr. Opin. Genet. Dev. 9, 447–454 (1999).
15. Angus-Hill, M. L., Elbert, K. M., Hidalgo, J. & Capecchi, M. R. T-cell factor 4
functions as a tumor suppressor whose disruption modulates colon cell
proliferation and tumorigenesis. Proc. Natl Acad. Sci. USA 108, 4914–4919
(2011).
16. Beildeck, M. E., Islam, M., Shah, S., Welsh, J. & Byers, S. W. Control of TCF-4
expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. PLoS ONE 4, e7872 (2009).

Ofﬁcial journal of the Cell Death Differentiation Association

Page 19 of 20

17. Barker, N., Huls, G., Korinek, V. & Clevers, H. Restricted high level expression of
Tcf-4 protein in intestinal and mammary gland epithelium. Am. J. Pathol. 154,
29–35 (1999).
18. Nguyen, H. et al. Tcf3 and Tcf4 are essential for long-term homeostasis of skin
epithelia. Nat. Genet. 41, 1068–1075 (2009).
19. van Es, J. H. et al. A critical role for the Wnt effector Tcf4 in adult intestinal
homeostatic self-renewal. Mol. Cell. Biol. 32, 1918–1927 (2012).
20. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J.
Clin. Invest. 119, 1420–1428 (2009).
21. Boyer, A. S. et al. TGFbeta2 and TGFbeta3 have separate and sequential
activities during epithelial-mesenchymal cell transformation in the embryonic
heart. Dev. Biol. 208, 530–545 (1999).
22. Cano, A. et al. The transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76–83 (2000).
23. Jakowlew, S. B. Transforming growth factor-beta in cancer and metastasis.
Cancer Metastasis Rev. 25, 435–457 (2006).
24. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science
331, 1559–1564 (2011).
25. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal
transitions in development and disease. Cell 139, 871–890 (2009).
26. Ikeuchi, Y. et al. TIF1gamma protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modiﬁer (SUMO) E3 ligase for the
transcriptional regulator SnoN1. J. Biol. Chem. 289, 25067–25078 (2014).
27. Chandhoke, A. S. et al. The ubiquitin ligase Smurf2 suppresses TGFbetainduced epithelial-mesenchymal transition in a sumoylation-regulated manner. Cell Death Differ. 23, 876–888 (2016).
28. Hebner, C., Weaver, V. M. & Debnath, J. Modeling morphogenesis and
oncogenesis in three-dimensional breast epithelial cultures. Annu. Rev. Pathol.
3, 313–339 (2008).
29. Mueller-Klieser, W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am. J. Physiol. 273, C1109–C1123 (1997).
30. Simian, M. & Bissell, M. J. Organoids: a historical perspective of thinking in three
dimensions. J. Cell Biol. 216, 31–40 (2017).
31. Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelialmesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 (2014).
32. Poy, F., Lepourcelet, M., Shivdasani, R. A. & Eck, M. J. Structure of a human Tcf4beta-catenin complex. Nat. Struct. Biol. 8, 1053–1057 (2001).
33. Rasanen, K. & Vaheri, A. TGF-beta1 causes epithelial-mesenchymal transition in
HaCaT derivatives, but induces expression of COX-2 and migration only in
benign, not in malignant keratinocytes. J. Dermatol. Sci. 58, 97–104 (2010).
34. Lamouille, S. & Derynck, R. Cell size and invasion in TGF-beta-induced epithelial
to mesenchymal transition is regulated by activation of the mTOR pathway. J.
Cell Biol. 178, 437–451 (2007).
35. Hatta, M., Miyake, Y., Uchida, K. & Yamazaki, J. Keratin 13 gene is epigenetically
suppressed during transforming growth factor-beta1-induced epithelialmesenchymal transition in a human keratinocyte cell line. Biochem. Biophys.
Res. Commun. 496, 381–386 (2018).
36. Lurbke, A. et al. Limited TCF7L2 expression in MS lesions. PLoS ONE 8, e72822
(2013).
37. Burwinkel, B. et al. Transcription factor 7-like 2 (TCF7L2) variant is associated
with familial breast cancer risk: a case-control study. BMC Cancer 6, 268 (2006).
38. Boj, S. F. et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic
response to perinatal and adult metabolic demand. Cell 151, 1595–1607
(2012).
39. Gloyn, A. L., Braun, M. & Rorsman, P. Type 2 diabetes susceptibility gene
TCF7L2 and its role in beta-cell function. Diabetes 58, 800–802 (2009).
40. Duval, A. et al. Frequent frameshift mutations of the TCF-4 gene in colorectal
cancers with microsatellite instability. Cancer Res. 59, 4213–4215 (1999).
41. Ravindranath, A. et al. Wnt-beta-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer. Br. J. Cancer
105, 542–551 (2011).
42. Shulewitz, M. et al. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in
breast cancer. Oncogene 25, 4361–4369 (2006).
43. Hou, N. et al. Transcription factor 7-like 2 mediates canonical Wnt/beta-catenin
signaling and c-Myc upregulation in heart failure. Circ. Heart Fail. https://doi.
org/10.1161/CIRCHEARTFAILURE.116.003010 (2016).
44. Sousa, A. G. et al. TCF7L2 polymorphism rs7903146 is associated with coronary
artery disease severity and mortality. PLoS ONE 4, e7697 (2009).
45. Bright-Thomas, R. M. & Hargest, R. APC, beta-Catenin and hTCF-4; an unholy
trinity in the genesis of colorectal cancer. Eur. J. Surg. Oncol. 29, 107–117
(2003).

Karve et al. Cell Death and Disease (2020)11:704

46. Chen, S. J., Yuan, W., Lo, S., Trojanowska, M. & Varga, J. Interaction of smad3
with a proximal smad-binding element of the human alpha2(I) procollagen
gene promoter required for transcriptional activation by TGF-beta. J. Cell.
Physiol. 183, 381–392 (2000).
47. Nakano, N. et al. Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene. J. Biol. Chem. 285, 38023–38033 (2010).
48. Comijn, J. et al. The two-handed E box binding zinc ﬁnger protein SIP1
downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267–1278 (2001).
49. Vandewalle, C. et al. SIP1/ZEB2 induces EMT by repressing genes of different
epithelial cell-cell junctions. Nucleic Acids Res. 33, 6566–6578 (2005).
50. Sarker, K. P. et al. ING2 as a novel mediator of transforming growth factor-betadependent responses in epithelial cells. J. Biol. Chem. 283, 13269–13279 (2008).
51. Chandhoke, A. C. Karve, K. Deng, L. & Bonni, S. The PIAS3-Smurf2 sumoylation
pathway suppresses breast cancer organoid invasiveness. Oncotarget https://
doi.org/10.18632/oncotarget.15471 (2017).

Ofﬁcial journal of the Cell Death Differentiation Association

Page 20 of 20

52. Imamichi, Y., Konig, A., Gress, T. & Menke, A. Collagen type I-induced Smadinteracting protein 1 expression downregulates E-cadherin in pancreatic
cancer. Oncogene 26, 2381–2385 (2007).
53. Sarker, K. P., Wilson, S. M. & Bonni, S. SnoN is a cell type-speciﬁc mediator of
transforming growth factor-beta responses. J. Biol. Chem. 280, 13037–13046
(2005).
54. Nikitorowicz-Buniak, J., Denton, C. P., Abraham, D. & Stratton, R. Partially
evoked epithelial-mesenchymal transition (EMT) is associated with
increased TGFbeta signaling within lesional scleroderma skin. PLoS ONE 10,
e0134092 (2015).
55. Chanda, A. et al. Identiﬁcation of the SUMO E3 ligase PIAS1 as a potential
survival biomarker in breast cancer. PLoS ONE 12, e0177639 (2017).
56. Pot, I. et al. Identiﬁcation of a novel link between the protein kinase
NDR1 and TGFbeta signaling in epithelial cells. PLoS ONE 8, e67178
(2013).

